PodcastGauging the Impact of High-Impact Drugs in Workers’ Comp
… represent a major area of pharmaceutical development with significant costs. These products do have evidence to support use, but place in therapy and proper patient selection are critical, … and are a continued source of concern in the workers’ compensation space, ranking in the top spot among the therapeutic classes at 18.4% of total drug cost in 2023, and that’s an … may be a viable option for select patients. You know, that’s always a consideration, but they do require careful oversight. And, in many cases, given their lack of demonstrated superiority …